Jiashen Y. Zhang
Yantai, 264003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Targeting immunoglobulin superfamily member 9 (IGSF9) to overcome acute myeloid leukemia resistance to CAR-T therapy.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 15, 2026
IGSF9-targeted therapy inhibits the progression of acute myeloid leukemia.
Journal: Blood advances
Published: March 12, 2025
Human placental mesenchymal stem cells regulate the antioxidant capacity of CD8+PD-1+ T cells through the CD73/ADO/Nrf2 pathway to protect against liver damage in mice with acute graft-versus-host disease.
Journal: Molecular immunology
Published: December 01, 2024
Correction: hPMSCs protects against D-galactose-induced oxidative damage of CD4+ T cells through activating Akt-mediated Nrf2 antioxidant signaling.
Journal: Stem cell research & therapy
Published: November 08, 2024
Corrigendum to "Human placental mesenchymal stromal cells modulate IFN-γ and IL-10 secretion by CD4+T cells via CD73, and alleviate intestinal damage in mice with graft-versus-host disease" [Int. Immunopharmacol. 124 (2023) 110767].
Journal: International immunopharmacology
Published: September 14, 2024
Human placental mesenchymal stromal cells promote the formation of CD8+CD122+PD-1+Tregs via CD73/Foxo1 to alleviate liver injury in graft-versus-host disease mice.
Journal: International immunopharmacology
Published: April 25, 2024
LILRB4 on multiple myeloma cells promotes bone lesion by p-SHP2/NF-κB/RELT signal pathway.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 21, 2024
hPMSCs Regulate the Level of TNF-α and IL-10 in Th1 Cells and Improve Hepatic Injury in a GVHD Mouse Model via CD73/ADO/Fyn/Nrf2 Axis.
Journal: Inflammation
Published: June 19, 2023
Human placental mesenchymal stromal cells modulate IFN-γ and IL-10 secretion by CD4+T cells via CD73, and alleviate intestinal damage in mice with graft-versus-host disease.
Journal: International immunopharmacology
Published: April 20, 2023
hPMSCs-Derived Exosomal miRNA-21 Protects Against Aging-Related Oxidative Damage of CD4+ T Cells by Targeting the PTEN/PI3K-Nrf2 Axis.
Journal: Frontiers in immunology
Published: September 21, 2021
hPMSCs inhibit the expression of PD-1 in CD4+IL-10+ T cells and mitigate liver damage in a GVHD mouse model by regulating the crosstalk between Nrf2 and NF-κB signaling pathway.
Journal: Stem cell research & therapy
Published: January 27, 2021
Last Updated: 09/26/2026